Chemotherapy in EGFR-mutated NSCLC: optimizing combinations with TKIs and amivantamab
Nature Reviews Clinical Oncology – Recent results from the FLAURA2 and MARIPOSA-2 trials underline the continued role of chemotherapy in the treatment of patients with EGFR-mutated non-small-cell…